Caisse DE Depot ET Placement DU Quebec Has $98.57 Million Stock Position in Colgate-Palmolive Company $CL

Key Points

• Caisse de Depot et Placement du Quebec increased its holdings in Colgate-Palmolive Company by 6,322 shares, bringing its total stake to 1,052,006 shares, valued at approximately $98.6 million.
• Colgate-Palmolive reported $0.92 EPS for its most recent quarter, exceeding analysts' expectations of $0.89, with revenues of $5.11 billion.
• The company's most recent quarterly dividend was $0.52 per share, with a dividend yield of 2.5% and a payout ratio of 58.43%.

Caisse DE Depot ET Placement DU Quebec grew its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 0.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,052,006 shares of the company's stock after purchasing an additional 6,322 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned about 0.13% of Colgate-Palmolive worth $98,573,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Personal CFO Solutions LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at approximately $285,000. Vision Capital Management Inc. acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at approximately $322,000. Autumn Glory Partners LLC raised its position in shares of Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after buying an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at approximately $2,166,000. Finally, Penserra Capital Management LLC increased its stake in Colgate-Palmolive by 398.6% in the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock valued at $997,000 after acquiring an additional 8,515 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded up $0.62 during mid-day trading on Friday, reaching $84.04. The company had a trading volume of 3,934,689 shares, compared to its average volume of 4,939,822. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a market cap of $67.92 billion, a P/E ratio of 23.61, a P/E/G ratio of 4.37 and a beta of 0.35. The business has a fifty day simple moving average of $87.15 and a 200 day simple moving average of $89.85.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the business posted $0.91 earnings per share. The company's quarterly revenue was up 1.0% on a year-over-year basis. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a $0.52 dividend. The ex-dividend date was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Analysts Set New Price Targets

CL has been the subject of several research analyst reports. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. Citigroup lowered their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research report on Monday, August 4th. Finally, Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.